Nemedio Revenue and Competitors
Estimated Revenue & Valuation
- Nemedio's estimated annual revenue is currently $2.3M per year.
- Nemedio's estimated revenue per employee is $251,000
Employee Data
- Nemedio has 9 Employees.
- Nemedio grew their employee count by 0% last year.
Nemedio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Quality Assurance | Reveal Email/Phone |
2 | Senior Validation Engineer | Reveal Email/Phone |
3 | Project Engineer | Reveal Email/Phone |
Nemedio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $352.6M | 878 | 6% | $323.5M | N/A |
#2 | $9.3M | 37 | 12% | N/A | N/A |
#3 | $36.4M | 145 | 2% | N/A | N/A |
#4 | $7M | 28 | 0% | N/A | N/A |
#5 | $1M | 4 | -88% | N/A | N/A |
#6 | $7.5M | 21 | -9% | $6.5M | N/A |
#7 | $6M | 24 | 4% | N/A | N/A |
#8 | $13.1M | 52 | 4% | N/A | N/A |
#9 | $17.1M | 68 | -17% | N/A | N/A |
#10 | $27.9M | 111 | 4% | N/A | N/A |
What Is Nemedio?
Backed by a team of seasoned medical device experts, neMedIO radically de-risks and simplifies the development process for medical devices. We provide the framework, process, tools, knowledge, and connections to go from prototype to market for traditional, high-tech, and robotic medical devices.
keywords:N/A
N/A
Total Funding
9
Number of Employees
$2.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nemedio News
2022-04-19 - Reunión virtual entre AMLO y Biden ne medio de oleada ...
El presidente estadounidense Joe Biden mantendrá este viernes una reunión virtual con su homólogo mexicano Andrés Manuel López Obrador para...
2022-04-13 - José Antonio Neme dio la bienvenida a Karla Constant al matinal
La mañana de este lunes 18 de abril, volvió a la conducción del matinal Mucho Gusto, el periodista José Antonio Neme. Publicidad.
Other Companies in Brooklyn
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 9 | N/A | N/A |
#2 | $0.1M | 9 | -18% | $11.9M |
#3 | $0.9M | 9 | -36% | N/A |
#4 | $0.9M | 9 | -36% | N/A |
#5 | $0.7M | 9 | -10% | N/A |